[3,2-c]Pyrazole-androst-4-en-17β-ol
98%
- Product Code: 110015
CAS:
929042-39-7
| Molecular Weight: | 312.5 g./mol | Molecular Formula: | C₂₀H₂₈N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of steroidal drugs, particularly those targeting hormonal regulation and metabolic processes. Its structure is often modified to develop potential therapeutic agents for conditions such as hormone-dependent cancers, endocrine disorders, and inflammatory diseases. Additionally, it is explored for its potential in designing selective enzyme inhibitors, which can be critical in treating various pathological conditions. Researchers also investigate its role in improving the bioavailability and efficacy of steroidal compounds in drug formulations.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | £904.18 |
+
-
|
[3,2-c]Pyrazole-androst-4-en-17β-ol
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of steroidal drugs, particularly those targeting hormonal regulation and metabolic processes. Its structure is often modified to develop potential therapeutic agents for conditions such as hormone-dependent cancers, endocrine disorders, and inflammatory diseases. Additionally, it is explored for its potential in designing selective enzyme inhibitors, which can be critical in treating various pathological conditions. Researchers also investigate its role in improving the bioavailability and efficacy of steroidal compounds in drug formulations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :